{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:28:36Z","timestamp":1791361716276,"version":"4.3.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1124\/jpet.122.001525","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T13:55:10Z","timestamp":1680702910000},"page":"180-192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Pharmacokinetic and Pharmacodynamic Consequences of Cytochrome P450 3A Inhibition on Mitragynine Metabolism in Rats"],"prefix":"10.1016","volume":"385","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1664-1692","authenticated-orcid":false,"given":"Shyam H.","family":"Kamble","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9644-0750","authenticated-orcid":false,"given":"Samuel","family":"Obeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5064-2381","authenticated-orcid":false,"given":"Francisco","family":"Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis F.","family":"Restrepo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara I.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2868-8073","authenticated-orcid":false,"given":"Erin C.","family":"Berthold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6087-6587","authenticated-orcid":false,"given":"Siva Rama Raju","family":"Kanumuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea R.","family":"Gamez-Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria L.C.","family":"Pallares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avi","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas P.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aidan","family":"Hampson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"McCurdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance R.","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5594-061X","authenticated-orcid":false,"given":"Jenny L.","family":"Wilkerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0553-4039","authenticated-orcid":false,"given":"Abhisheak","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takato","family":"Hiranita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.122.001525_bib1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.tetlet.2013.11.031","article-title":"Isolation, characterization, and NMR spectroscopic data of indole and oxindole alkaloids from Mitragyna speciosa","volume":"55","author":"Ali","year":"2014","journal-title":"Tetrahedron Lett"},{"key":"10.1124\/jpet.122.001525_bib2","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1016\/0024-3205(83)90638-0","article-title":"Evaluation of the interactions of mu and delta selective ligands with [3H]D-Ala2-D-Leu5-enkephalin binding to mouse brain membranes","volume":"33","author":"Barrett","year":"1983","journal-title":"Life Sci"},{"key":"10.1124\/jpet.122.001525_bib3","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1124\/dmd.121.000640","article-title":"The lack of contribution of 7-hydroxymitragynine to the antinociceptive effects of mitragynine in mice: a pharmacokinetic and pharmacodynamic study","volume":"50","author":"Berthold","year":"2022","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.122.001525_bib4","doi-asserted-by":"crossref","first-page":"16553","DOI":"10.1021\/acs.jmedchem.1c01111","article-title":"Oxidative metabolism as a modulator of kratom\u2019s biological actions","volume":"64","author":"Chakraborty","year":"2021","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.122.001525_bib5","first-page":"334","article-title":"Evaluation of the effects of ketoconazole and voriconazole on the pharmacokinetics of oxcarbazepine and its main metabolite MHD in rats by UPLC\u2013MS-MS","volume":"54","author":"Chen","year":"2016","journal-title":"J Chromatogr Sci"},{"key":"10.1124\/jpet.122.001525_bib6","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.122.001525_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11011-011-9274-6","article-title":"Morphine metabolism, transport and brain disposition","volume":"27","author":"De Gregori","year":"2012","journal-title":"Metab Brain Dis"},{"key":"10.1124\/jpet.122.001525_bib8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-2125.1998.00679.x","article-title":"Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes","volume":"45","author":"Eagling","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/jpet.122.001525_bib9","article-title":"Kratom: history, pharmacology, current user trends, adverse health effects and potential benefits","volume":"2022","author":"Grundmann","year":"2022","journal-title":"Dis Mon"},{"key":"10.1124\/jpet.122.001525_bib10","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1007\/s00213-015-3866-5","article-title":"Discriminative stimulus properties of mitragynine (kratom) in rats","volume":"232","author":"Harun","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.122.001525_bib11","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.neubiorev.2012.11.012","article-title":"From kratom to mitragynine and its derivatives: physiological and behavioural effects related to use, abuse, and addiction","volume":"37","author":"Hassan","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1124\/jpet.122.001525_bib12","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/adb.12639","article-title":"Abuse liability and therapeutic potential of the Mitragyna speciosa (kratom) alkaloids mitragynine and 7-hydroxymitragynine","volume":"24","author":"Hemby","year":"2019","journal-title":"Addict Biol"},{"key":"10.1124\/jpet.122.001525_bib13","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1007\/s00213-019-05247-7","article-title":"The effects of mitragynine and morphine on schedule-controlled responding and antinociception in rats","volume":"236","author":"Hiranita","year":"2019","journal-title":"Psychopharmacology (Berl)"},{"issue":"Suppl 1","key":"10.1124\/jpet.122.001525_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1096\/fasebj.2020.34.s1.05180","article-title":"Potential contribution of 7-hydroxymitragynine, a metabolite of the primary kratom (Mitragyna speciosa) alkaloid mitragynine, to the \u03bc-opioid activity of mitragynine in rats","volume":"34","author":"Hiranita","year":"2020","journal-title":"FASEB J"},{"key":"10.1124\/jpet.122.001525_bib15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0378-8741(88)90121-3","article-title":"Ethnopharmacology of kratom and the Mitragyna alkaloids","volume":"23","author":"Jansen","year":"1988","journal-title":"J Ethnopharmacol"},{"key":"10.1124\/jpet.122.001525_bib16","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.toxlet.2019.11.005","article-title":"Exploration of cytochrome P450 inhibition mediated drug-drug interaction potential of kratom alkaloids","volume":"319","author":"Kamble","year":"2020","journal-title":"Toxicol Lett"},{"key":"10.1124\/jpet.122.001525_bib17","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1080\/00498254.2018.1552819","article-title":"Metabolite profiling and identification of enzymes responsible for the metabolism of mitragynine, the major alkaloid of Mitragyna speciosa (kratom)","volume":"49","author":"Kamble","year":"2019","journal-title":"Xenobiotica"},{"key":"10.1124\/jpet.122.001525_bib18","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.2042-7158.1988.tb06293.x","article-title":"Enhanced bioavailability of morphine after rectal administration in rats","volume":"40","author":"Katagiri","year":"1988","journal-title":"J Pharm Pharmacol"},{"key":"10.1124\/jpet.122.001525_bib19","first-page":"811","article-title":"Pharmacokinetics of morphine in rats with adjuvant-induced arthritis","volume":"31","author":"Kimura","year":"2017","journal-title":"In Vivo"},{"key":"10.1124\/jpet.122.001525_bib20","doi-asserted-by":"crossref","first-page":"6754","DOI":"10.1021\/jacs.6b00360","article-title":"Synthetic and receptor signaling explorations of the Mitragyna alkaloids: mitragynine as an atypical molecular framework for opioid receptor modulators","volume":"138","author":"Kruegel","year":"2016","journal-title":"J Am Chem Soc"},{"key":"10.1124\/jpet.122.001525_bib21","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1021\/acscentsci.9b00141","article-title":"7-Hydroxymitragynine is an active metabolite of mitragynine and a key mediator of its analgesic effects","volume":"5","author":"Kruegel","year":"2019","journal-title":"ACS Cent Sci"},{"key":"10.1124\/jpet.122.001525_bib22","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0014-2999(85)90431-5","article-title":"[3H]U-69593 a highly selective ligand for the opioid \u03ba receptor","volume":"109","author":"Lahti","year":"1985","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.122.001525_bib23","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1080\/00498250701570269","article-title":"Development of an in vivo rat screen model to predict pharmacokinetic interactions of CYP3A4 substrates","volume":"37","author":"Mandlekar","year":"2007","journal-title":"Xenobiotica"},{"key":"10.1124\/jpet.122.001525_bib24","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s002130050905","article-title":"Ketoconazole blocks the stress-induced reinstatement of cocaine-seeking behavior in rats: relationship to the discriminative stimulus effects of cocaine","volume":"142","author":"Mantsch","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.122.001525_bib25","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/j.lfs.2003.09.054","article-title":"Antinociceptive effect of 7-hydroxymitragynine in mice: discovery of an orally active opioid analgesic from the Thai medicinal herb Mitragyna speciosa","volume":"74","author":"Matsumoto","year":"2004","journal-title":"Life Sci"},{"key":"10.1124\/jpet.122.001525_bib26","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1016\/j.lfs.2005.09.030","article-title":"Partial agonistic effect of 9-hydroxycorynantheidine on \u03bc-opioid receptor in the guinea-pig ileum","volume":"78","author":"Matsumoto","year":"2006","journal-title":"Life Sci"},{"key":"10.1124\/jpet.122.001525_bib27","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1055\/a-1212-5475","article-title":"Pharmacokinetics and safety of mitragynine in beagle dogs","volume":"86","author":"Maxwell","year":"2020","journal-title":"Planta Med"},{"key":"10.1124\/jpet.122.001525_bib28","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1021\/acs.jmedchem.9b01465","article-title":"Investigation of the adrenergic and opioid binding affinities, metabolic stability, plasma protein binding properties, and functional effects of selected indole-based kratom alkaloids","volume":"63","author":"Obeng","year":"2020","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.122.001525_bib29","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/jpet.122.001192","article-title":"Interactive effects of \u00b5-opioid and adrenergic-\u03b12 receptor agonists in rats: pharmacological investigation of the primary kratom alkaloid mitragynine and its metabolite 7-hydroxymitragynine","volume":"383","author":"Obeng","year":"2022","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.122.001525_bib30","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1124\/jpet.120.000189","article-title":"Pharmacological comparison of mitragynine and 7-hydroxymitragynine: in vitro affinity and efficacy for \u03bc-opioid receptor and opioid-like behavioral effects in rats","volume":"376","author":"Obeng","year":"2021","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.122.001525_bib31","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0014-5793(94)01341-W","article-title":"DAMGO, a \u03bc-opioid receptor selective agonist, distinguishes between \u03bc- and \u03b4-opioid receptors around their first extracellular loops","volume":"357","author":"Onogi","year":"1995","journal-title":"FEBS Lett"},{"key":"10.1124\/jpet.122.001525_bib32","doi-asserted-by":"crossref","first-page":"283","DOI":"10.4103\/0250-474X.159613","article-title":"Effect of water miscible organic solvents on p-nitrophenol hydroxylase (CYP2E1) activity in rat liver microsomes","volume":"77","author":"Patil","year":"2015","journal-title":"Indian J Pharm Sci"},{"key":"10.1124\/jpet.122.001525_bib33","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1055\/s-2006-959578","article-title":"A new indole alkaloid, 7 alpha-hydroxy-7H-mitragynine, from Mitragyna speciosa in Thailand","volume":"60","author":"Ponglux","year":"1994","journal-title":"Planta Med"},{"key":"10.1124\/jpet.122.001525_bib34","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.drugpo.2019.05.003","article-title":"Kratom policy: the challenge of balancing therapeutic potential with public safety","volume":"70","author":"Prozialeck","year":"2019","journal-title":"Int J Drug Policy"},{"key":"10.1124\/jpet.122.001525_bib35","doi-asserted-by":"crossref","first-page":"382","DOI":"10.4103\/0250-474X.164783","article-title":"Effect of water-miscible organic solvents on CYP450-mediated metoprolol and imipramine metabolism in rat liver microsomes","volume":"77","author":"Shah","year":"2015","journal-title":"Indian J Pharm Sci"},{"key":"10.1124\/jpet.122.001525_bib36","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1002\/dta.2604","article-title":"Simultaneous quantification of ten key kratom alkaloids in Mitragyna speciosa leaf extracts and commercial products by ultra-performance liquid chromatography-tandem mass spectrometry","volume":"11","author":"Sharma","year":"2019","journal-title":"Drug Test Anal"},{"key":"10.1124\/jpet.122.001525_bib37","doi-asserted-by":"crossref","first-page":"e2582","DOI":"10.1002\/hup.2582","article-title":"Changing trends in the use of kratom (Mitragyna speciosa) in Southeast Asia","volume":"32","author":"Singh","year":"2017","journal-title":"Hum Psychopharmacol"},{"key":"10.1124\/jpet.122.001525_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2019.112462","article-title":"Patterns and reasons for kratom (Mitragyna speciosa) use among current and former opioid poly-drug users","volume":"249","author":"Singh","year":"2020","journal-title":"J Ethnopharmacol"},{"key":"10.1124\/jpet.122.001525_bib39","series-title":"Statistical Methods","author":"Snedecor","year":"1967"},{"key":"10.1124\/jpet.122.001525_bib40","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1080\/02791072.2015.1096434","article-title":"Experiences of kratom users: a qualitative analysis","volume":"47","author":"Swogger","year":"2015","journal-title":"J Psychoactive Drugs"},{"key":"10.1124\/jpet.122.001525_bib41","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.drugalcdep.2017.10.012","article-title":"Kratom use and mental health: a systematic review","volume":"183","author":"Swogger","year":"2018","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.122.001525_bib42","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1021\/jm010576e","article-title":"Studies on the synthesis and opioid agonistic activities of mitragynine-related indole alkaloids: discovery of opioid agonists structurally different from other opioid ligands","volume":"45","author":"Takayama","year":"2002","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.122.001525_bib44A","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0304-3959(02)00041-6","article-title":"The interaction index: a measure of drug synergism","volume":"98","author":"Tallarida","year":"2002","journal-title":"Pain"},{"key":"10.1124\/jpet.122.001525_bib43","doi-asserted-by":"crossref","first-page":"620","DOI":"10.3390\/pharmaceutics14030620","article-title":"Clinical pharmacokinetic assessment of kratom (Mitragyna speciosa), a botanical product with opioid-like effects, in healthy adult participants","volume":"14","author":"Tanna","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1124\/jpet.122.001525_bib44","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2147\/SAR.S164261","article-title":"Current perspectives on the impact of kratom use","volume":"10","author":"Veltri","year":"2019","journal-title":"Subst Abuse Rehabil"},{"key":"10.1124\/jpet.122.001525_bib45","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00414-015-1279-y","article-title":"The pharmacology and toxicology of kratom: from traditional herb to drug of abuse","volume":"130","author":"Warner","year":"2016","journal-title":"Int J Legal Med"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524004464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524004464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.122.001525","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T13:29:13Z","timestamp":1739971753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524004464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0022356524004464"],"URL":"https:\/\/doi.org\/10.1124\/jpet.122.001525","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetic and Pharmacodynamic Consequences of Cytochrome P450 3A Inhibition on Mitragynine Metabolism in Rats","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.122.001525","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"U.S. Government work not protected by U.S. copyright.","name":"copyright","label":"Copyright"}]}}